| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Debra L Morris is Director at BTMD and has filed Form 4s across 3 companies. Debra L Morris's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.1M at current prices.
The biggest single holding is REXR (~$797K) as Director.
Debra L Morris has 16 Form 4 filings on record from December 2020 to May 2026, across 3 companies: Director at Progyny (PGNY), 2025–2026; Director at Rexford Industrial Realty (REXR), 2020–2026; Director at biote (BTMD), 2022–2026.
The 25 reported transactions were 13 option or other derivative awards, 8 stock awards, 3 option exercises and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $90K and no sales.
The only open-market purchase was 30,000 shares of BTMD at an average $3.00 on January 9, 2023, about $90K. Twelve months later BTMD was up 41%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | BTMD Biote Corp. | Director | Buy | 30,000 | $3.00 | $90,000.00 | New | +75.5% | +40.6% |